193
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound

ORCID Icon, , , , ORCID Icon, , & show all
Pages 4329-4340 | Published online: 01 Jun 2021

References

  • Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37:284–289. doi:10.1007/s00134-010-2043-x20857280
  • Aw A, Carrier M, Koczerginski J, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 2012;130:323–326.22444157
  • Bertoglio S, Faccini B, Lalli L, et al. Peripherally Inserted Central Catheters (PICCs) in cancer patients under chemotherapy: a prospective study on the incidence of complications and overall failures. J Surg Oncol. 2016;113(6):708–714. doi:10.1002/jso.2422027020965
  • Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382(9889):311–325. doi:10.1016/S0140-6736(13)60592-923697825
  • Chopra V, Fallouh N, McGuirk H, et al. Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: a nested case–control study. Thromb Res. 2015;135(5):829–834. doi:10.1016/j.thromres.2015.02.01225726426
  • Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312–319. doi:10.1111/j.1538-7836.2010.04126.x21040443
  • Haddad RA, Alnimer Y, Abdalla A, et al. Is peripherally inserted central catheter–related thrombosis associated with ABO blood group? A case–control pilot study. Clin Appl Thromb Hemost. 2018;24(8):1297–1300. doi:10.1177/107602961877028929683035
  • Menéndez JJ, Verdú C, Calderón B, et al. Incidence and risk factors of superficial and deep venous thrombosis associated with peripherally inserted central catheters in children. J Thromb Haemost. 2016;14:2158–2168. doi:10.1111/jth.1347827558946
  • Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889–2934. doi:10.1016/j.jacc.2013.11.00224239923
  • Li J, Fan YY, Xin MZ, et al. A randomised, controlled trial comparing the long-term effects of peripherally inserted central catheter placement in chemotherapy patients using B-mode ultrasound with modified Seldinger technique versus blind puncture. Eur J Oncol Nurs. 2014;18:94–103. doi:10.1016/j.ejon.2013.08.00324018351
  • Kang J, Chen W, Sun W, et al. Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days. J Vasc Access. 2017;18:153–157. doi:10.5301/jva.500067028218366
  • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149:315–352. doi:10.1016/j.chest.2015.11.02626867832
  • Needleman L, Cronan JJ, Lilly MP, et al. Ultrasound for lower extremity deep venous thrombosis multidisciplinary recommendations from the society of radiologists in ultrasound consensus conference. Circulation. 2018;137:1505–1515. doi:10.1161/CIRCULATIONAHA.117.03068729610129
  • Jezovnik MK, Poredos P. Factors influencing the recanalisation rate of deep venous thrombosis. Int Angiol. 2012;31:169–175.22466983
  • Al-Asadi O, Almusarhed M, Eldeeb H. Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study. Thromb J. 2019;17:2. doi:10.1186/s12959-019-0191-y30697126
  • Liu Y, Gao Y, Wei L, et al. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation. Ther Clin Risk Manag. 2015;11:153–160. doi:10.2147/TCRM.S7337925673995
  • Zochios V, Umar I, Simpson N, et al. Peripherally inserted central catheter (PICC)-related thrombosis in critically ill patients. J Vasc Access. 2014;15:329–337. doi:10.5301/jva.500023924811591
  • Dentali F, Sironi AP, Ageno W, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost. 2012;38:535–548. doi:10.1055/s-0032-131575822740183
  • Ward SE, O’Sullivan JM, O’Donnell JS. The relationship between ABO blood group, von Willebrand factor and primary hemostasis. Blood. 2020;136:2864–2874. doi:10.1182/blood.202000584332785650
  • Garam N, Maláti É, Sinkovits G, et al. Platelet count, ADAMTS13 activity, von willebrand factor level and survival in patients with colorectal cancer: 5-year Follow-up Study. Thromb Haemost. 2018;118(01):123–131. doi:10.1160/TH17-07-054829304532
  • Yi XL, Chen J, Li J, et al. Risk factors associated with PICC-related upper extremity venous thrombosis in cancer patients. J Clin Nurs. 2014;23:837–843. doi:10.1111/jocn.1222723710585
  • Shi Y, Wen L, Zhou Y, et al. Thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter. J Int Med Res. 2014;42:863–869. doi:10.1177/030006051452706124781722
  • Ageno W, Becattini C, Brighton T, et al. Cardiovascular risk factors and venous thromboembolism A meta-analysis. Circulation. 2008;117(1):93–102. doi:10.1161/CIRCULATIONAHA.107.70920418086925
  • Ting HJ, Stice JP, Schaff UY, et al. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-alpha. Circ Res. 2007;100:381–390. doi:10.1161/01.RES.0000258023.76515.a317234968
  • Antignani PL, Allegra C, Fareed J. Treatment of deep vein thrombosis with rivaroxaban and its potential to prevent the post-thrombotic syndrome. Int Angiol. 2019;38:17–21. doi:10.23736/S0392-9590.18.04031-230465419
  • Aguiar de Sousa D, Lucas Neto L, Arauz A, et al. Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation. Stroke. 2020;51:1174–1181. doi:10.1161/STROKEAHA.119.02853232114929